Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)
Ipca Labs Q1 FY27 results show strong performance. Consolidated revenue grew 21% year-on-year to INR2,788 crores, with EBITDA margins expanding significantly to 22.88% (up 4.49 percentage points). Domestic formulations rose 13%, exports 34%, and API business 30%. Management increased FY27 growth outlook to 14-16% and consolidated EBITDA margin guidance to...